As part of KSL’s continuing commitment to our community and advancing research, KSL is excited to announce a new partnership with the University at Buffalo’s Center for Advanced Technology in Big Data and Health Sciences (UB CAT) during 2021-22.
Amy Jacobs, PhD, Research Associate Professor in the Department of Microbiology & Immunology at University at Buffalo will be serving as the Principal Investigator along with Lakshmanan Suresh, DDS, MS, PhD, at KSL in a project titled “Risk Stratification of COVID 19 Vaccinated Individuals based on Antibody Levels.”
Previous studies published by KSL have shown that antibody levels can drop over time, and with the uncertainty of antibody levels and protection against new COVID-19 variants, especially in the immunocompromised, this study will be more important than ever. This study will explore the optimum antibody neutralization titers following vaccination and may provide objective measures of when a person may require booster vaccine dose.
"KSL is proud to continue to partner with the University at Buffalo, and we look forward to the fruit of our research leading to a better understanding of COVID-19, improving the health and safety of our community, and to help New York State's life sciences sector grow to help protect human lives," Dr. Suresh said.
For published papers and other resources related to this project, please see the links below.